Life sciences today

Life sciences has entered an era of unprecedented disruption, demand and digitalization

The COVID-19 pandemic has ushered in a new, disruptive era where agile, innovative life sciences organizations have collaborated to rapidly accelerate the pace of R&D and commercialization, coupled with a laser focus on evidence-based outcomes, delivering value and improving patient experience.

Life sciences CEOs are ready for change

47%

of life sciences CEOs say —

Building an innovative culture is key; more than for any other industry.

Collaborative innovation is a core capability for life sciences R&D, illustrated during the COVID-19 pandemic through its vaccine programs.

50%

of life sciences CEOs say —

Partnerships have become more important since the COVID-19 pandemic.

They expect more partnering opportunities over the next 2–3 years, 38% more than global outperformers.

68%

of life sciences CEOs say —

Cloud will help them deliver results they desire over the next 2-3 years.

AI (57%) and IoT (75%) are also expected to help deliver results for life sciences CEOs.

Industry recognition

IBM has been consistently recognized as a leader by some of the most influential industry analysts.

Inspired leadership

Our partnerships

We work with strategic partners to create industry-leading solutions that enable our clients to thrive in the era of hybrid multicloud and AI.

SAP logo
Adobe logo
Salesforce logo
Microsoft logo
AWS logo
ServiceNow logo

Get the best of IBM in your inbox

Subscribe to curated newsletters for the latest in technology, business and thought leadership.